Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Misonix Inc (MSON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 95,472
  • Shares Outstanding, K 9,360
  • Annual Sales, $ 27,270 K
  • Annual Income, $ -1,680 K
  • 36-Month Beta 0.21
  • Price/Sales 3.38
  • Price/Cash Flow 0.00
  • Price/Book 3.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.30 +9.68%
on 08/23/17
10.80 -5.56%
on 09/05/17
+0.25 (+2.51%)
since 08/22/17
3-Month
7.05 +44.68%
on 07/11/17
10.90 -6.42%
on 08/22/17
+0.53 (+5.48%)
since 06/22/17
52-Week
4.85 +110.31%
on 10/12/16
12.00 -15.00%
on 03/28/17
+4.95 (+94.29%)
since 09/22/16

Most Recent Stories

More News
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of the Securities of Misonix, Inc. - MSON

The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit...

MSON : 10.20 (+3.55%)
Corporate News Blog - Medtronic Voluntarily Recalls Diabetes Infusion Sets Worldwide

Research Desk Line-up: Misonix Post Earnings Coverage

MSON : 10.20 (+3.55%)
MDT : 79.70 (+0.21%)
Misonix Appoints Joseph Dwyer as Chief Financial Officer

Misonix, Inc. (Nasdaq:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that Joseph P. Dwyer has been appointed as Chief Financial...

MSON : 10.20 (+3.55%)
Misonix Reports Fiscal Year 2017 Financial Results

Misonix, Inc. (Nasdaq:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today financial results for the fourth quarter and fiscal...

MSON : 10.20 (+3.55%)
Investor Network: MISONIX INC to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 22, 2017 / MISONIX INC (NASDAQ: MSON) will be discussing their earnings results in their Q4 Earnings Call to be held August 22, 2017 at 4:30 PM Eastern Time.

MSON : 10.20 (+3.55%)
Misonix, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, August 22, 2017

Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report financial results for the fourth...

MSON : 10.20 (+3.55%)
Misonix Reports Third Quarter Fiscal Year 2017 Financial Results

Misonix, Inc. (Nasdaq:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today financial results for the three and nine months ended...

MSON : 10.20 (+3.55%)
Investor Network: MISONIX INC to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 2, 2017 / MISONIX INC (NASDAQ: MSON) will be discussing their earnings results in their Q3 Earnings Call to be held May 2, 2017 at 4:30 PM Eastern Time.

MSON : 10.20 (+3.55%)
Misonix, Inc. To Report Third Quarter Fiscal Year 2017 Financial Results On Tuesday, May 2, 2017

Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report financial results for the third...

MSON : 10.20 (+3.55%)
Misonix, Inc. To Review Financial Results for First Half of Fiscal Year 2017 On Tuesday, March 14, 2017

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will conduct a conference call to review the...

MSON : 10.20 (+3.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Misonix, Inc. designs, develops, manufactures, and markets medical, scientific, and industrial ultrasonic equipment, laboratory safety equipment, and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position...

See More

Support & Resistance

2nd Resistance Point 10.63
1st Resistance Point 10.42
Last Price 10.20
1st Support Level 9.87
2nd Support Level 9.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.